SlideShare ist ein Scribd-Unternehmen logo
1 von 32
Aligning the Activities and Goals of Medical Science Liaison Teams for Strengthened Corporate Sustainability   Dr. Samuel Dyer CEO and Founder The Medical Science Liaison Corporation www.MSLWORLD.com
Agenda About me, The Medical Science Liaison Corporation, MSL World.com Demonstrating value of the expensive MSL and advisor roles to the company Examining the disconnect between field based medical and corporate initiatives Acquiring and synthesizing field insights to drive clinical and corporate decision-making The data slides represent findings collected from 11 European-based companies’ MSL management teams. Key Definitions MSL Activities Performance Metrics Team Structure and Staffing
About Me 10 years experience within International Medical Affairs Led MSL / Medical Teams in multiple TA’s in over 60 countries throughout the U.S., Canada, Europe, Africa, Middle East, New Zealand and Australia. Been hired as a consultant by McKinsey, Bain & Co. consulting companies and Philips Healthcare to work on MSL projects  Sit on the management team /board of advisors for the start up Biotech company-Biognosys Wrote a first of its kind book on the MSL/MA role that is expected to be published in the fall of this year Formed the Medical Science Liaison Corporation along with a team of professionals that operates among other functions www.MSLWORLD.com
About Medical Science Liaison Corporation & ww.MSLWORLD.com After numerous discussions with hiring managers, recruiters and HR personnel around the world it was decided that there was a need to have a source of career related resources for the MSL/MA role MSL Corp. is completely focused on the MSL/MA  Career.  Our goal is the bring the best resources around the world together for MSL/MA professionals  Provide original articles, publications, books etc. focused on MSL MSL WORLD is the industry’s first and only comprehensive niche career management site 100% dedicated, focused and built to serve the Medical Science Liaison (MSL) career.
Resources & Methodology This analysis is based on Cutting Edge Information’s existing database of information on MSL benchmarks, management strategy and best practices. The data presented herein have been collected directly from senior-level executives in Europe through research-based engagements designed to analyze companies’ MSL strategies.   A note about company blindings:  In order to be able to collect this data, Cutting Edge Information uses a blinding procedure that requires us to separate specific data sets from the names of the companies that provided that information and from the specific brands for which the data are relevant.  This approach to data collection and analysis enables us to reliably collect data that most companies consider proprietary and/or highly sensitive.
MSL Activities
Key Definitions: Abbreviations Data Slides uses the following abbreviations: ,[object Object]
KOL:  Key Opinion Leader
HCP: Healthcare Provider
IITs: Investigator-Initiated Trials
PCP: Primary Care Provider
FTEs: Full-Time Equivalents,[object Object]
Initial Phase of MSL Support for a Drug: Europe n=11
Latest Stage of MSL Support for a Drug: Europe n=11
MSLs’ Time per Activity for a Pre-Launch Product: Europe n=11
MSLs’ Time per Activity for a Post-Launch Product: Europe n=10
Percentage of MSL Teams That Conduct the Following Activities for Pre-Launch Products: Europe n=11
Percentage of MSL Teams That Conduct the Following Activities for Post-Launch Products: Europe n=10
Percentage of MSLs’ Time Spent per Activity for a Pre-Launch Product: Europe n=11
Percentage of MSLs’ Time Spent per Activity for a Post-Launch Product: Europe n=10
Performance Metrics
Measuring MSL/MA Value There is little to no data or studies that have looked at ROI metrics with hard numbers for the return on investment for an MSL/MA There is no industry standard or definitive measure at this point MSL team managers and companies are still trying to figure out how to measure ROI on MSL, they all know the value is there but the hard metrics are really not indicative of the quality of the MSL-KOL relationships Each company measures a MSL team contributions a little different by establish various performance metrics to demonstrate the value that a MSL/MA team brings to the company.
Type and Number of Interactions per Thought Leader, Annually: Europe n=10
Number of Performance Metrics Used by Companies in Europe
Percentage of European Companies Using Specific Performance Metrics n=11
“External Value” Performance Metrics: Europe n=11
“Internal Value” Performance Metrics: Europe n=11
Team Structure and Staffing
Criteria Used to Establish MSL Staffing Level (US and Europe) Criteria Percentage of Companies Using Each Criterion n=50
Ratio of Thought Leader Relationships to MSLs in Europe n=11
Ratio of Sales Reps to MSLs in Europe n=11
Level of Executive with Oversight over MSL Teams at European Companies n=10

Weitere ähnliche Inhalte

Was ist angesagt?

Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Eularis
 

Was ist angesagt? (20)

Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
 
Medical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory ComplianceMedical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory Compliance
 
Gaps in Medical Science Liaison Training
Gaps in Medical Science Liaison TrainingGaps in Medical Science Liaison Training
Gaps in Medical Science Liaison Training
 
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsKey Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
 
KOL MANAGEMENT
KOL MANAGEMENTKOL MANAGEMENT
KOL MANAGEMENT
 
KOL Relationship & Brand Building in Pharma Marketing
KOL Relationship & Brand Building in Pharma MarketingKOL Relationship & Brand Building in Pharma Marketing
KOL Relationship & Brand Building in Pharma Marketing
 
Kol program management and marketing functional trans genomics
Kol program management and marketing functional trans genomicsKol program management and marketing functional trans genomics
Kol program management and marketing functional trans genomics
 
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketing
 
Key Opinion Leader Management
Key Opinion Leader ManagementKey Opinion Leader Management
Key Opinion Leader Management
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol management
 
Pharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force EffectivenessPharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force Effectiveness
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
 
Scheifele Sept09final
Scheifele Sept09finalScheifele Sept09final
Scheifele Sept09final
 
Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)
 
Optimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryOptimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report Summary
 
Digital and Social Media in Pharma
Digital and Social Media in PharmaDigital and Social Media in Pharma
Digital and Social Media in Pharma
 
Training Program for Medical Representatives by Anup Soans
Training Program for Medical Representatives by Anup Soans Training Program for Medical Representatives by Anup Soans
Training Program for Medical Representatives by Anup Soans
 
Be a Smart Manager not just a good one!
Be a Smart Manager not just a good one!Be a Smart Manager not just a good one!
Be a Smart Manager not just a good one!
 
Pro pl brand plan
Pro pl brand planPro pl brand plan
Pro pl brand plan
 

Ähnlich wie Medical Science Liaison-Aligning The Activities And Goals Of Medical Science Liaison Teams For Strengthened Corporate Sustainability

Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES .docx
Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES     .docxRunning Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES     .docx
Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES .docx
healdkathaleen
 
2018 re con capabilitieslinkedin
2018 re con capabilitieslinkedin2018 re con capabilitieslinkedin
2018 re con capabilitieslinkedin
Sal Cofoni
 
Managing Alliances with the Balanced ScorecardFifty pe.docx
Managing Alliances with the Balanced ScorecardFifty pe.docxManaging Alliances with the Balanced ScorecardFifty pe.docx
Managing Alliances with the Balanced ScorecardFifty pe.docx
croysierkathey
 
Alessandro Cortese - Business planning in associations, a theoretical approac...
Alessandro Cortese - Business planning in associations, a theoretical approac...Alessandro Cortese - Business planning in associations, a theoretical approac...
Alessandro Cortese - Business planning in associations, a theoretical approac...
visitbrussels
 
Qualification Statement
Qualification StatementQualification Statement
Qualification Statement
pocomo05
 
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
aulasnilda
 
Example of use of theory in assignments.pdfExample of use .docx
Example of use of theory in assignments.pdfExample of use .docxExample of use of theory in assignments.pdfExample of use .docx
Example of use of theory in assignments.pdfExample of use .docx
cravennichole326
 
Employee retention startegies in Pharmaceutical companies:Case of lebanon
Employee retention startegies in Pharmaceutical companies:Case of lebanonEmployee retention startegies in Pharmaceutical companies:Case of lebanon
Employee retention startegies in Pharmaceutical companies:Case of lebanon
Bassima Hazima
 
Vishal Meswani-New Resume
Vishal Meswani-New ResumeVishal Meswani-New Resume
Vishal Meswani-New Resume
Vishal Meswani
 
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docxNEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
henrymartin15260
 
Pierre Bacot Consulting General Capabilities 2016
Pierre Bacot Consulting General Capabilities 2016Pierre Bacot Consulting General Capabilities 2016
Pierre Bacot Consulting General Capabilities 2016
Pierre Bacot
 

Ähnlich wie Medical Science Liaison-Aligning The Activities And Goals Of Medical Science Liaison Teams For Strengthened Corporate Sustainability (20)

Development Msl
Development MslDevelopment Msl
Development Msl
 
Medical Affairs Consortium
Medical Affairs Consortium Medical Affairs Consortium
Medical Affairs Consortium
 
Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES .docx
Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES     .docxRunning Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES     .docx
Running Head BELLEVUE HOSPITAL AND THE HEART HEALTH SERVICES .docx
 
2018 re con capabilitieslinkedin
2018 re con capabilitieslinkedin2018 re con capabilitieslinkedin
2018 re con capabilitieslinkedin
 
Corporate Affairs Excellence
Corporate Affairs ExcellenceCorporate Affairs Excellence
Corporate Affairs Excellence
 
Managing Alliances with the Balanced ScorecardFifty pe.docx
Managing Alliances with the Balanced ScorecardFifty pe.docxManaging Alliances with the Balanced ScorecardFifty pe.docx
Managing Alliances with the Balanced ScorecardFifty pe.docx
 
Luchetti_Laura_CV 8.16_Linkedin
Luchetti_Laura_CV 8.16_LinkedinLuchetti_Laura_CV 8.16_Linkedin
Luchetti_Laura_CV 8.16_Linkedin
 
Alessandro Cortese - Business planning in associations, a theoretical approac...
Alessandro Cortese - Business planning in associations, a theoretical approac...Alessandro Cortese - Business planning in associations, a theoretical approac...
Alessandro Cortese - Business planning in associations, a theoretical approac...
 
Qualification Statement
Qualification StatementQualification Statement
Qualification Statement
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
 
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
14 hours agoNikesh Bantu Discussion 1COLLAPSETop of Form.docx
 
Educating the Market--Creating Value Through Support of Continuing Medical Ed...
Educating the Market--Creating Value Through Support of Continuing Medical Ed...Educating the Market--Creating Value Through Support of Continuing Medical Ed...
Educating the Market--Creating Value Through Support of Continuing Medical Ed...
 
Example of use of theory in assignments.pdfExample of use .docx
Example of use of theory in assignments.pdfExample of use .docxExample of use of theory in assignments.pdfExample of use .docx
Example of use of theory in assignments.pdfExample of use .docx
 
A shock to the system
A shock to the systemA shock to the system
A shock to the system
 
Employee retention startegies in Pharmaceutical companies:Case of lebanon
Employee retention startegies in Pharmaceutical companies:Case of lebanonEmployee retention startegies in Pharmaceutical companies:Case of lebanon
Employee retention startegies in Pharmaceutical companies:Case of lebanon
 
Vishal Meswani-New Resume
Vishal Meswani-New ResumeVishal Meswani-New Resume
Vishal Meswani-New Resume
 
Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2
 
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docxNEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
NEW PRODUCT DEVELOPMENT FOR THE COMPANY DELL INC.ANALYZING THE.docx
 
Strategic Thinking, TCF and Action Plans
Strategic Thinking, TCF and Action PlansStrategic Thinking, TCF and Action Plans
Strategic Thinking, TCF and Action Plans
 
Pierre Bacot Consulting General Capabilities 2016
Pierre Bacot Consulting General Capabilities 2016Pierre Bacot Consulting General Capabilities 2016
Pierre Bacot Consulting General Capabilities 2016
 

Kürzlich hochgeladen

The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
daisycvs
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
instagramfab782445
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
laloo_007
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
daisycvs
 

Kürzlich hochgeladen (20)

Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 

Medical Science Liaison-Aligning The Activities And Goals Of Medical Science Liaison Teams For Strengthened Corporate Sustainability

  • 1. Aligning the Activities and Goals of Medical Science Liaison Teams for Strengthened Corporate Sustainability Dr. Samuel Dyer CEO and Founder The Medical Science Liaison Corporation www.MSLWORLD.com
  • 2. Agenda About me, The Medical Science Liaison Corporation, MSL World.com Demonstrating value of the expensive MSL and advisor roles to the company Examining the disconnect between field based medical and corporate initiatives Acquiring and synthesizing field insights to drive clinical and corporate decision-making The data slides represent findings collected from 11 European-based companies’ MSL management teams. Key Definitions MSL Activities Performance Metrics Team Structure and Staffing
  • 3. About Me 10 years experience within International Medical Affairs Led MSL / Medical Teams in multiple TA’s in over 60 countries throughout the U.S., Canada, Europe, Africa, Middle East, New Zealand and Australia. Been hired as a consultant by McKinsey, Bain & Co. consulting companies and Philips Healthcare to work on MSL projects  Sit on the management team /board of advisors for the start up Biotech company-Biognosys Wrote a first of its kind book on the MSL/MA role that is expected to be published in the fall of this year Formed the Medical Science Liaison Corporation along with a team of professionals that operates among other functions www.MSLWORLD.com
  • 4. About Medical Science Liaison Corporation & ww.MSLWORLD.com After numerous discussions with hiring managers, recruiters and HR personnel around the world it was decided that there was a need to have a source of career related resources for the MSL/MA role MSL Corp. is completely focused on the MSL/MA Career. Our goal is the bring the best resources around the world together for MSL/MA professionals Provide original articles, publications, books etc. focused on MSL MSL WORLD is the industry’s first and only comprehensive niche career management site 100% dedicated, focused and built to serve the Medical Science Liaison (MSL) career.
  • 5. Resources & Methodology This analysis is based on Cutting Edge Information’s existing database of information on MSL benchmarks, management strategy and best practices. The data presented herein have been collected directly from senior-level executives in Europe through research-based engagements designed to analyze companies’ MSL strategies. A note about company blindings: In order to be able to collect this data, Cutting Edge Information uses a blinding procedure that requires us to separate specific data sets from the names of the companies that provided that information and from the specific brands for which the data are relevant. This approach to data collection and analysis enables us to reliably collect data that most companies consider proprietary and/or highly sensitive.
  • 7.
  • 8. KOL: Key Opinion Leader
  • 11. PCP: Primary Care Provider
  • 12.
  • 13. Initial Phase of MSL Support for a Drug: Europe n=11
  • 14. Latest Stage of MSL Support for a Drug: Europe n=11
  • 15. MSLs’ Time per Activity for a Pre-Launch Product: Europe n=11
  • 16. MSLs’ Time per Activity for a Post-Launch Product: Europe n=10
  • 17. Percentage of MSL Teams That Conduct the Following Activities for Pre-Launch Products: Europe n=11
  • 18. Percentage of MSL Teams That Conduct the Following Activities for Post-Launch Products: Europe n=10
  • 19. Percentage of MSLs’ Time Spent per Activity for a Pre-Launch Product: Europe n=11
  • 20. Percentage of MSLs’ Time Spent per Activity for a Post-Launch Product: Europe n=10
  • 22. Measuring MSL/MA Value There is little to no data or studies that have looked at ROI metrics with hard numbers for the return on investment for an MSL/MA There is no industry standard or definitive measure at this point MSL team managers and companies are still trying to figure out how to measure ROI on MSL, they all know the value is there but the hard metrics are really not indicative of the quality of the MSL-KOL relationships Each company measures a MSL team contributions a little different by establish various performance metrics to demonstrate the value that a MSL/MA team brings to the company.
  • 23. Type and Number of Interactions per Thought Leader, Annually: Europe n=10
  • 24. Number of Performance Metrics Used by Companies in Europe
  • 25. Percentage of European Companies Using Specific Performance Metrics n=11
  • 26. “External Value” Performance Metrics: Europe n=11
  • 27. “Internal Value” Performance Metrics: Europe n=11
  • 28. Team Structure and Staffing
  • 29. Criteria Used to Establish MSL Staffing Level (US and Europe) Criteria Percentage of Companies Using Each Criterion n=50
  • 30. Ratio of Thought Leader Relationships to MSLs in Europe n=11
  • 31. Ratio of Sales Reps to MSLs in Europe n=11
  • 32. Level of Executive with Oversight over MSL Teams at European Companies n=10
  • 33. Acquiring and synthesizing field insights to drive clinical and corporate decision-making Best Practices Shared: 12 companies-28 MSL Directors/MSL’s across Europe, Asia, U.S. Industry study-reports that KOL development as the second most important product-launch expenditure Centralized database needed for the sharing of information across multiple cross functional areas (Medical, Sales, Marketing)-this can be FREE and SIMPLE-Not much $ needed Complete alignment of internal activities and planning Dissemination of information/sharing of KOL interactions Calendar of KOL activities that is shared between Medical and Sales for better alignment Write up summary of KOL field visit-Sales and Marketing have access to information Have a clear specific plan for each KOL (i.e. Ad Boards, speaking engagements etc.) for the Quarter, 1 year and 2 year timeframes etc. Set up marketing/medical bi-weekly meetings to discuss tactical and strategic items including: KOL lectures, workshops, planned visits, training territory/KOL issues etc. Create monthly team teleconferences Create and present to all sales colleagues (NSM)-updates, challenges and wins at sales training, cycle meeting and teleconferences etc. Create internal multiple TA/Product Medical Meetings to share best practices, approaches, and opportunities Identify further opportunities for cross functional collaboration TALK and COMMUNICATE! NO SILOS!
  • 34. Examining the disconnect between field based medical and corporate initiatives The Problem #1 complaint given by MSL teams across the U.S./Europe/Asia There is a strong disconnect of the communication between field based MSL/MA team and corporate Medical Affairs A problem occurs when decisions are made at the corporate level or initiatives have begun (like working with KOL’s) and there has not been direct communication with field MSL/MA teams and/or there is a poor/slow communication channel Most common problem occurs when there is a change, delay or not clear communication on corporate clinical strategy. MSL/MA working with a KOL may generate a IIT lead/idea. MSL may work with a KOL on IIT to write/submit a proposal though the IIT is no longer aligned with corporate strategy. Result: valuable opportunities are lost, expensive resources are wasted and KOL’s lose confidence in the company due to lack of direct and/or timely communication. Company credibility can be damaged.
  • 35. Examining the disconnect between field based medical and corporate initiatives To prevent a disconnect: Corporate Medical Affairs and field based MSL/MA teams should have ongoing dialog concerning goals, initiatives, KOL activities and successes Establish communication processes between home office, field Medical AND also marketing and sales Communicate strategy and needs as changes occur WITH KOL’s! Revisit strategies regularly to make sure they are still aligned with the goals of the company A good relationship between departments where channels of communication are open is critical to a company's success. When the Medical, sales and marketing departments have regular communication. Get all departments involved with KOL/MSL/MA activities. Prevent communication silos!
  • 36. Contact Dr. Samuel Dyer CEO/Founderwww.MSLWORLD.com samuel.dyer@mslworld.com ___________________________________________________________________ Acknowledgements: Thanks to Cutting Edge Information & Yanis Saradjian for providing slides and information throughout this presentation. Yanis Saradjian Director of Consulting-Cutting Edge Info. Durham +1 919-433-0206 Boston +1 781-530-3785 Yanis_saradjian@cuttingedgeinfo.com
  • 37. THANK YOU ANY QUESTIONS

Hinweis der Redaktion

  1. Surveyed MSL teams use an average of 6.5 performance measures. This slide shows how many teams use specific measures of MSL’s value to external stakeholders — based on whether teams used an above-average or below-average number of metrics.
  2. Surveyed MSL teams use an average of 6.5 performance measures. This slide shows how many teams use specific measures of MSL’s value to internal stakeholders — based on whether teams used an above-average or below-average number of metrics.
  3. Though not limited to European companies, this graph shows the mindset behind MSL staffing decisions at 50 surveyed pharmaceutical companies, including the 11 European companies.